Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer findings from University of Federico II described
January 22nd, 2009
According to a study from Naples, Italy, " Several analyses suggest an increase of brain metastases in HER2 over-expressing breast cancers treated with trastuzumab as compared to historical series of unselected patients. Patients and methods We analyzed the incidence of central nervous system (CNS) metastases in 78 patients with HER2 over-expressing breast cancer treated with trastuzumab between July 2000 and June 2006 at the Oncology Department of University Federico II in Naples." "We also characterized and compared patients with and without CNS involvement. The median follow-up was 35.3 months (95% CI 26.3-44); median overall survival was 56 months (95% CIs 46-nr);...
Source: Women's Health Weekly (2009-01-22)
|
